Current/ Expected Orderbook/ Pending Orders?

As of the latest call, the management indicated there is improved visibility on the order book compared to earlier levels. The company sees restocking happening on the chemical side, suggesting positive momentum in orders. Punit Makharia mentioned that the trust level about order visibility seen in Q4 FY23-24 has been maintained and is expected to improve further in coming quarters. No specific numeric values for current or expected order book/pending orders were disclosed during the call. The outlook is optimistic, anticipating better demand and growth post the first quarter of FY24-25.

Any current/future capex/capital investment/strategic investment?

Current capex pipeline of approximately INR 200 crores focused on chemical, fertilizer, and renewable energy sectors. Around 50-60% of future capacity expansion is towards backward integration, which improves bottom-line without significantly impacting top-line. INR 20-22 crores being spent on expanding solar power capacity; total solar investment around INR 37-38 crores with a 3.8 MW plant recently completed and plans for a 9 MW combined solar capacity. Capital work in progress (CWIP) closing balance is INR 42 crores — INR 16 crores in solar and INR 33.46 crores in chemical and fertilizer exp

Future growth expectations in sales/revenue/volumes?

For FY25, expected revenue growth is around 15%-20%, targeting approximately INR 875 to INR 935 crores. The company anticipates reaching over INR 1,100 crores in revenue by FY26. Capacity utilization is expected to improve from 65% to around 75% in FY24-25, enhancing productivity by 10%. Volume growth observed in chemicals (26% YoY increase in FY24) and dyes intermediates (82% volume growth in FY24). Fertilizer segment expected to support growth, with improved subsidy levels and decent offtake anticipated due to the good monsoon forecast. Gradual improvement in business phases: new c

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects approximately 15%-20% growth in both top line and bottom line for FY25. For FY25, a revenue range of INR 875 to INR 935 crores is anticipated. For FY26, the company targets a revenue of around INR 1,100 crores. EBITDA margin is expected to be around 10% for FY25-26, with cautious optimism given geopolitical factors. PAT margins are targeted around 10% in the near term. Improvements in fertilizer segment subsidy and expected decent offtake support growth projections. Backward integration and solar power project capex will enhance profitability and cost efficiency

Sh.Pushkar Chem.Q4 FY24Chemicals & Petrochemicals

Sh.Pushkar Chem. Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹492P/E: 22.7Market Cap: ₹1.6K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

Yes

Order

Yes

Capex

Yes

4 of 5 growth signals are positive — a strong management growth story.

Full analysis

Revenue guidance

Category 3

For FY25, expected revenue growth is around 15%-20%, targeting approximately INR 875 to INR 935 crores.
The company anticipates reaching over INR 1,100 crores in revenue by FY26.
Capacity utilization is expected to improve from 65% to around 75% in FY24-25, enhancing productivity by 10%.
Volume growth observed in chemicals (26% YoY increase in FY24) and dyes intermediates (82% volume growth in FY24).
Fertilizer segment expected to support growth, with improved subsidy levels and decent offtake anticipated due to the good monsoon forecast.
Gradual improvement in business phases: new chemical expansions (Unit 5 and Unit 6) and solar projects to contribute in phases across FY25 and beyond.
Management expects EBITDA margins to stabilize around 10% in the near term with improved profitability alongside revenue growth.

Margin guidance

Category 1

The company expects approximately 15%-20% growth in both top line and bottom line for FY25.
For FY25, a revenue range of INR 875 to INR 935 crores is anticipated.
For FY26, the company targets a revenue of around INR 1,100 crores.
EBITDA margin is expected to be around 10% for FY25-26, with cautious optimism given geopolitical factors.
PAT margins are targeted around 10% in the near term.
Improvements in fertilizer segment subsidy and expected decent offtake support growth projections.
Backward integration and solar power project capex will enhance profitability and cost efficiency, positively impacting future earnings.
Management is confident that operational efficiencies and strategic investments will deliver long-term value and improved earnings visibility soon.

See what Sh.Pushkar Chem. management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

- No explicit mention of any new fundraising through debt or equity in the recent discussions. - The planned capex of INR 215 crores is primarily funded through internal accruals and a preferential issue to the promoter (Page 3). - Solar expansion investment of around INR 37-38 crores is planned without taking any debt or loan (Page 14). - Current bank borrowings include INR 107 crores, mostly non-funded limits, not additional new debt (Page 7-8). - No indication of new equity fundraising campaigns or debt issuances was discussed in the Q&A or management remarks. In summary, the company is funding its capex mainly via internal accruals and promoter preferential issue, with no new debt or equity fundraising currently planned or disclosed.

Order book

Yes

As of the latest call, the management indicated there is improved visibility on the order book compared to earlier levels.
The company sees restocking happening on the chemical side, suggesting positive momentum in orders.
Punit Makharia mentioned that the trust level about order visibility seen in Q4 FY23-24 has been maintained and is expected to improve further in coming quarters.
No specific numeric values for current or expected order book/pending orders were disclosed during the call.
The outlook is optimistic, anticipating better demand and growth post the first quarter of FY24-25.

See what Sh.Pushkar Chem. management said on order book — free account, 30 seconds.

Capex plans

Yes

Current capex pipeline of approximately INR 200 crores focused on chemical, fertilizer, and renewable energy sectors.
Around 50-60% of future capacity expansion is towards backward integration, which improves bottom-line without significantly impacting top-line.
INR 20-22 crores being spent on expanding solar power capacity; total solar investment around INR 37-38 crores with a 3.8 MW plant recently completed and plans for a 9 MW combined solar capacity.
Capital work in progress (CWIP) closing balance is INR 42 crores — INR 16 crores in solar and INR 33.46 crores in chemical and fertilizer expansions.
Fertilizer capacity expansions include Unit 6 with 1,50,000 tons and Unit 4 water-soluble fertilizer plant with 12,000 tons capacity, expected to be commercialized in the near term.
Planned capex of INR 215 crores funded mainly through internal accruals and preferential promoter issue.

Track Sh.Pushkar Chem. — get its next earnings analysis in your feed

How does Sh.Pushkar Chem. rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisSh.Pushkar Chem.

Rev 3Mar 1

See where Sh.Pushkar Chem. sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Sh.Pushkar Chem. rank in Chemicals & Petrochemicals?

Compare Sh.Pushkar Chem. against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Sh.Pushkar Chem.'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →